165 related articles for article (PubMed ID: 25980931)
1. Circulating tumor cells in prostate cancer: Does (nuclear) size matter?
Pal SK; Agarwal N; Jones JO
Cancer; 2015 Sep; 121(18):3190-2. PubMed ID: 25980931
[No Abstract] [Full Text] [Related]
2. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.
Chen JF; Ho H; Lichterman J; Lu YT; Zhang Y; Garcia MA; Chen SF; Liang AJ; Hodara E; Zhau HE; Hou S; Ahmed RS; Luthringer DJ; Huang J; Li KC; Chung LW; Ke Z; Tseng HR; Posadas EM
Cancer; 2015 Sep; 121(18):3240-51. PubMed ID: 25975562
[TBL] [Abstract][Full Text] [Related]
3. The origin of prostate metastases: emerging insights.
Santoni M; Piva F; Scarpelli M; Cheng L; Lopez-Beltran A; Massari F; Iacovelli R; Berardi R; Santini D; Montironi R
Cancer Metastasis Rev; 2015 Dec; 34(4):765-73. PubMed ID: 26363603
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of circulating prostate carcinoma cells.
Wang ZP; Eisenberger MA; Carducci MA; Partin AW; Scher HI; Ts'o PO
Cancer; 2000 Jun; 88(12):2787-95. PubMed ID: 10870062
[TBL] [Abstract][Full Text] [Related]
5. [Circulating tumor cells and advanced prostate cancer].
Murez T; Droupy S; Rebillard X; Alix-Panabieres C
Bull Cancer; 2012 Jul; 99 Suppl 1():S4-15. PubMed ID: 22569300
[TBL] [Abstract][Full Text] [Related]
6. In vivo flow cytometry: a new method for enumerating circulating cancer cells.
Georgakoudi I; Solban N; Novak J; Rice WL; Wei X; Hasan T; Lin CP
Cancer Res; 2004 Aug; 64(15):5044-7. PubMed ID: 15289300
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer.
Mitas MC; Chaudhary UB; Marshall DT; Gattoni-Celli S
Am J Hematol; 2008 Jan; 83(1):87. PubMed ID: 17724705
[No Abstract] [Full Text] [Related]
8. Disseminated tumor cells and dormancy in prostate cancer metastasis.
van der Toom EE; Verdone JE; Pienta KJ
Curr Opin Biotechnol; 2016 Aug; 40():9-15. PubMed ID: 26900985
[TBL] [Abstract][Full Text] [Related]
9. [Molecular staging of prostatic cancer].
Ravery V
Prog Urol; 1997 Dec; 7(6):925-9. PubMed ID: 9490136
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.
Berezovskaya O; Schimmer AD; Glinskii AB; Pinilla C; Hoffman RM; Reed JC; Glinsky GV
Cancer Res; 2005 Mar; 65(6):2378-86. PubMed ID: 15781653
[TBL] [Abstract][Full Text] [Related]
11. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.
Glinskii AB; Smith BA; Jiang P; Li XM; Yang M; Hoffman RM; Glinsky GV
Cancer Res; 2003 Jul; 63(14):4239-43. PubMed ID: 12874032
[TBL] [Abstract][Full Text] [Related]
12. New circulating tumor cell technology could advance personalized medicine in prostate cancer.
Miller S
Nanomedicine (Lond); 2013 May; 8(5):683-4. PubMed ID: 23656263
[No Abstract] [Full Text] [Related]
13. A rapid imageable in vivo metastasis assay for circulating tumor cells.
Menen RS; Pinney E; Kolostova K; Bobek V; Suetsugu A; Zhang N; Bouvet M; Hoffman RM
Anticancer Res; 2011 Oct; 31(10):3125-8. PubMed ID: 21965717
[TBL] [Abstract][Full Text] [Related]
14. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.
Gonzales JC; Fink LM; Goodman OB; Symanowski JT; Vogelzang NJ; Ward DC
Clin Genitourin Cancer; 2011 Sep; 9(1):39-45. PubMed ID: 21723797
[TBL] [Abstract][Full Text] [Related]
15. [The detection of circulating prostatic cells using RT-PCR].
Eschwege P
Prog Urol; 1997 Feb; 7(1):92-6. PubMed ID: 9116747
[No Abstract] [Full Text] [Related]
16. Cellular interactions in prostate cancer genesis and dissemination. Looking beyond the obvious.
Tomuleasa C; Kacsó G; Soriţău O; Suşman S; Irimie A; Virág P
Rom J Morphol Embryol; 2010; 51(3):427-35. PubMed ID: 20809016
[TBL] [Abstract][Full Text] [Related]
17. TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer.
Sun H; Zhang L; Shi C; Hu P; Yan W; Wang Z; Duan Q; Lu F; Qin L; Lu T; Xiao J; Wang Y; Zhu F; Shao C
Oncotarget; 2015 May; 6(14):12392-404. PubMed ID: 25881543
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
[TBL] [Abstract][Full Text] [Related]
19. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells in prostate cancer: beyond enumeration.
Chen JF; Lu YT; Cheng S; Tseng HR; Figlin RA; Posadas EM
Clin Adv Hematol Oncol; 2017 Jan; 15(1):63-73. PubMed ID: 28212371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
